226. Antimicrobial Novel Agents: Saturday, 12:15 - 1:30 p.m.
Poster Session: Antimicrobial Novel Agents
Mark G Wise, PhD
Lead Scientist
IHMA
Schaumburg, Illinois, United States
Francis Arhin, PhD
Director, Developmental Microbiology
Pfizer, Inc.
Kirkland, Manitoba, Canada
Daniel F. Sahm, PhD
VP Global Microbiology Services & Chief Scientific Officer
IHMA
Schaumburg, Illinois, United States